The Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) is Germany’s federal regulatory authority for medicines and medical devices.
BfArM reviews clinical trial applications, oversees pharmacovigilance, and enforces compliance with EU regulations. Sponsors conducting research in Germany must obtain authorization from BfArM. Its oversight directly influences multinational trial timelines and reporting obligations.